Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Next Level Genomics is a specialized genomics service provider focused on high-quality long-read sequencing technologies. The company leverages platforms such as Pacific Biosciences (PacBio) and Oxford Nanopore to provide comprehensive genomic insights, including de novo assembly, structural variant detection, and full-length transcriptomics. Their services cater to academic, clinical, and pharmaceutical researchers seeking to resolve complex genomic regions that traditional short-read sequencing cannot address. By offering end-to-end solutions from sample preparation to bioinformatics analysis, Next Level Genomics enables advanced research in areas like rare disease, oncology, and agricultural biotechnology. As a PacBio Certified Service Provider, they maintain high standards for data quality and technical expertise in the rapidly evolving field of long-read genomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Next Level Genomics.